Our goal

At Medip Analytics, we help medical companies to showcase the added value of their medical technology with our easy-to-use cloud software. 

Our software is versatile and can be used for various purposes, including sales and marketing. By providing evidence-based insights into the value and impact of medical technologies, our software can help companies effectively communicate the benefits of their products to potential customers and investors. This can lead to increased sales, better market positioning, and improved business outcomes for biotech and medtech companies.

The software is intuitive and easily adjustable to fit different settings like specific hospitals or countries. It can show the cost-effectiveness of the product, return-on-investment for hospitals, impact on resource use (including personnel), existing literature on standard of care, and more. This accelerates market adoption of new Biotech and Medtech products.

New direction

From report to cloud

One of the key features of our software is its flexibility. Users can change important parameters of the underlying simulation models to make them specific to the setting of interest, such as a particular country, region, or hospital. This allows companies to tailor their evidence to the needs of different stakeholders and demonstrate the true value of their technology in a variety of settings.

The value of a technology can depend on many factors


Value of technology depends on the population in which it is used 
(e.g. low, intermediate and high risk)


Whether it is used in a small hospital or major academic centre might impact the value 


How current diagnostic and treatment pathways are defined significantly impacts the value of technology


Amongst other aspects, costs can differ between countries and therewith the country is an important factor in the value assessment 

Incremental technology

Adjustments to the technology can influence its value. For instance, AI technology is constantly developing and therewith the value is constantly changing  


The value can differ between individuals, depending on patient and disease characteristics

In collaboration with